48,466
edits
Difference between revisions of "Tubulocystic carcinoma of the kidney"
Jump to navigation
Jump to search
Tubulocystic carcinoma of the kidney (view source)
Revision as of 21:34, 22 August 2014
, 21:34, 22 August 2014→IHC
(→IHC) |
|||
| Line 69: | Line 69: | ||
*Vimentin +ve. | *Vimentin +ve. | ||
*AMACR +ve. | *AMACR +ve. | ||
*CK7 -ve/+ve (focally in 2/3 tumours<ref name=pmid23157747>{{Cite journal | last1 = Zhang | first1 = SH. | last2 = Shi | first2 = SF. | last3 = Huang | first3 = SF. | last4 = Zhang | first4 = YN. | last5 = Zheng | first5 = YY. | last6 = Chen | first6 = GY. | title = [Clinical and pathologic features of tubulocystic carcinoma of kidney]. | journal = Zhonghua Bing Li Xue Za Zhi | volume = 41 | issue = 8 | pages = 543-6 | month = Aug | year = 2012 | doi = | PMID = 23157747 }}</ref>). | |||
==See also== | ==See also== | ||